The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
This is an e-text about the historical and philosophical background of Psychology.
Open Science Tools Ltd. is a company dedicated to promoting Open Science through high-quality, minimal-cost tools like PsychoPy, PsychoJS, and Pavlovia.
The Department of Psychology at Maynooth University offers undergraduate and postgraduate programs, along with world-class research in areas such as clinical psychology, neuroscience, and social psychology.